Alzheimer's disease patients who took cholinesterase inhibitors to improve cognitive function were 34% less likely to die and experience myocardial infarction than non-users, researchers found. The risk of myocardial infarction was lowest among those who took the highest doses. The study, based on data from more than 7,000 patients in Sweden, was published in the European Heart Journal.
Alzheimer's drugs linked to lower death, heart attack risk
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||